查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1943548

抗菌产品市场－全球产业规模、份额、趋势、机会及预测（依产品、销售管道、地区及竞争格局划分，2021-2031年）

Antibacterial Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Sales Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球抗菌产品市场预计将从 2025 年的 273.6 亿美元成长到 2031 年的 333.6 亿美元，复合年增长率为 3.36%。

这些产品由专门设计的化学配方和材料构成，旨在消除或抑制皮肤、无生命物体和表面上的致病菌。市场成长的根本驱动力在于人们迫切需要减少医疗相关感染，以及公众健康意识的持续提升。这些关键驱动因素并非暂时的趋势，而是消费行为转变为预防性感染控制的结构性趋势。近期数据也印证了这一增长的需求：根据美国清洁协会 (ACI) 预测，到 2025 年，74% 的美国人将改变清洁习惯以改善自身健康。

市场概览
预测期 2027-2031
市场规模：2025年 273.6亿美元
市场规模：2031年 333.6亿美元
复合年增长率：2026-2031年 3.36%
成长最快的细分市场 在线的
最大的市场 北美洲

儘管市场需求强劲，但严格的环境安全和毒性法律规范严重阻碍了成长。监管机构正日益加强合规标准，以应对某些活性成分（例如三氯生）可能带来的生态学风险以及抗菌素抗药性问题。这种复杂的法规环境为新参与企业设置了重重障碍，并迫使现有製造商耗费巨资对其现有产品进行重新配方。因此，这些合规壁垒阻碍了创新解决方案的推出，并有可能减缓全球市场的整体扩张。

市场驱动因素

细菌性皮肤感染疾病和医疗相关感染的日益增加正在改变市场格局，对能够对抗抗药性病原体的先进配方提出了更高的要求。包括世界卫生组织（世卫组织）在内的国际卫生组织已将对抗抗菌素抗药性列为优先事项，从而创造了一种产品有效性与严格的公共卫生目标紧密相连的环境。这一趋势正在推动创新，并促使製造商专注于开发专为临床和机构使用而设计的高效产品，而非通用清洁产品。监管指南也强调了这一转变的迫切性。世卫组织于2024年5月发布的「2024年优先细菌病原体清单」将15种抗药性细菌列为首要任务，这直接加速了对标靶抗菌技术的投资，以应对这些生物威胁。

同时，抗菌剂在建筑和纺织领域的应用拓展，正将市场范围从传统的卫生用品扩展到更广泛的领域。在对持久被动防护需求的驱动下，抗菌涂层技术的进步使得抗菌功能得以整合到消费性纺织品和公共基础设施中。这种多元化发展为技术供应商带来了显着的收入成长。根据Polygene集团于2025年2月发布的2024年第四季中期报告，其净销售额成长了45%，显示市场对材料处理的需求强劲。此外，高乐氏公司（The Clorox Company）在2024年报告称，其健康与保健部门第一季的净销售额增长了38%，进一步印证了消费者对抗菌防护的持续信任。

市场挑战

全球抗菌产品市场面临的主要障碍之一是针对抗菌药物抗药性和环境毒性的严格监管。监管机构对活性成分的合规标准日益严格，迫使製造商投入大量资源重新设计现有产品，而非开发新产品。这种监管负担造成了严重的财务压力，挤占了原本用于满足安全要求的研发资金。因此，新型抗菌解决方案的研发週期不断延长，而高成本也为新竞争者进入市场设置了巨大的障碍。

这种限制性的法规环境对中小企业的影响尤其显着，而中小企业往往是利基创新的源泉，因为它们缺乏足够的财力来应对复杂的法律义务。压制这些小型企业严重限制了市场的成长潜力。根据国际肥皂、清洁剂和护理产品协会预测，到2024年，中小企业将营运该产业85%的生产设施。由于该行业如此大的产能依赖中小型製造商，它们无法负担不断上涨的监管成本，这将直接降低整体产能，并减缓整个行业的成长。

市场趋势

消费者对安全环保产品的需求日益增长，推动了天然植物抗菌成分的普及，从根本上改变了产品配方。製造商正加速以植物萃取物和生物基活性成分取代三氯生等合成杀菌剂，这些成分功效相近，但毒性较低。这一趋势在化妆品和个人护理领域尤其明显，「洁净标示」概念正推动着天然防护技术的研究与发展。儘早采用植物来源活性成分带来了经济效益。根据 Symrise AG 于 2025 年 1 月发布的 2024 年财务报告，受强劲的植物活性成分和微防护需求驱动，该公司化妆品原料部门预计将实现接近两位数的有机销售成长。

同时，永续和材料高效利用的包装正从一项合规要求转变为关键的竞争优势。各公司正在重新设计容器结构和分配系统，以显着减少塑胶消耗并采用循环设计原则，从而吸引具有环保意识的机构客户。这一趋势旨在减少卫生用品分发系统的碳足迹，同时保持抗菌配方的有效性。近期的一些创新表明了该行业对这一目标的承诺。根据GOJO Industries于2025年4月发布的《2023-2024年永续价值报告》，新款Purell ES10分配器比其前代产品减少了30%的塑胶用量，直接满足了市场减少废弃物的需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球抗菌产品市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品分类（洗手剂、沐浴乳、护手霜及润肤露等）
    • 依销售管道（超级市场/大卖场、专卖店、药局/药妆店、线上、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美抗菌产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲抗菌产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区抗菌产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲抗菌产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美抗菌产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球抗菌产品市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Reckitt Benckiser Group PLC
  • Unilever Plc
  • GOJO Industries, Inc.
  • Henkel Corporation
  • Johnson & Johnson
  • The Himalaya Drug Company
  • Bielenda
  • Colgate-Palmolive Company
  • Sebapharma GmbH & Co. KG
  • Farouk Systems, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 16012

The Global Antibacterial Products Market is projected to expand from USD 27.36 Billion in 2025 to USD 33.36 Billion by 2031, registering a CAGR of 3.36%. These products consist of chemical formulations and materials specifically designed to eliminate or suppress pathogenic bacteria on skin, inanimate objects, and surfaces. The market's growth is fundamentally driven by an urgent need to reduce healthcare-associated infections and a lasting increase in public awareness regarding hygiene. These primary drivers represent a structural shift in consumer behavior towards preventative infection control rather than temporary trends. This increased demand is substantiated by recent data; according to the American Cleaning Institute, in 2025, 74% of Americans modified their cleaning routines to enhance their health.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 27.36 Billion
Market Size 2031USD 33.36 Billion
CAGR 2026-20313.36%
Fastest Growing SegmentOnline
Largest MarketNorth America

Despite strong market demand, growth is significantly hindered by rigorous regulatory oversight regarding environmental safety and toxicity. Regulatory authorities are increasingly enforcing stricter compliance standards to address potential ecological risks and antimicrobial resistance linked to specific active ingredients such as triclosan. This complicated regulatory environment establishes substantial barriers for new market entrants and forces established manufacturers to undertake expensive reformulations of existing products. Consequently, these compliance hurdles challenge the deployment of innovative solutions and threaten to slow the overall expansion of the global market.

Market Driver

The escalating prevalence of bacterial skin infections and healthcare-associated infections is transforming the market by demanding advanced formulations capable of defeating resistant pathogens. Global health organizations are prioritizing the fight against antimicrobial resistance, creating an environment where product efficacy is closely tied to rigorous public health goals. This dynamic stimulates innovation, compelling manufacturers to focus on high-potency agents tailored for clinical and institutional use rather than general-purpose cleaners. The urgency of this shift is highlighted by regulatory guidance; according to the World Health Organization's May 2024 'Bacterial Priority Pathogens List 2024', 15 families of antibiotic-resistant bacteria were identified as critical priorities, directly accelerating investment in targeted antibacterial technologies to counter these biological threats.

Concurrently, the expansion of antibacterial agents into construction and textiles is broadening the market beyond traditional hygiene applications. Advances in antimicrobial coatings allow for the incorporation of germ-fighting capabilities into consumer textiles and public infrastructure, driven by a desire for continuous, passive protection. This sector diversification is yielding significant revenue increases for technology providers. According to the Polygiene Group's 'Interim Report Q4 2024' released in February 2025, net sales rose by 45%, indicating strong demand for material treatments. Furthermore, The Clorox Company reported in 2024 that net sales in its Health and Wellness segment grew by 38% in the first fiscal quarter, confirming the enduring consumer reliance on antibacterial interventions.

Market Challenge

A major obstacle facing the Global Antibacterial Products Market is the intense regulatory scrutiny regarding antimicrobial resistance and environmental toxicity. Authorities are mandating increasingly strict compliance standards for active ingredients, compelling manufacturers to allocate significant resources toward reformulating current products rather than innovating new ones. This regulatory burden imposes a severe financial constraint, diverting essential research and development funds to meet safety requirements. As a result, the development timeline for novel antibacterial solutions is prolonged, and the high costs associated with compliance create a formidable barrier that deters new competitors from entering the market.

This restrictive regulatory environment disproportionately affects smaller companies that are often sources of niche innovation but lack the financial resilience to manage complex legal obligations. The market's growth potential is heavily restricted when these smaller players are suppressed. According to the International Association for Soaps, Detergents and Maintenance Products, Small and Medium-sized Enterprises managed 85% of the sector's manufacturing facilities in 2024. Because such a large proportion of the industry's production capacity relies on smaller manufacturers, their inability to absorb rising regulatory costs directly reduces overall production capabilities and decelerates the sector's collective growth.

Market Trends

Consumer demand for safer, eco-friendly products is driving a shift toward natural and plant-based antibacterial ingredients, fundamentally altering product formulations. Manufacturers are increasingly replacing synthetic biocides like triclosan with botanical extracts and bio-based actives that provide similar efficacy without the associated toxicity concerns. This trend is especially prominent in the cosmetic and personal care sectors, where "clean label" preferences are fueling R&D into nature-derived protection. Early adoption of botanical efficacy is proving financially rewarding; according to Symrise AG's '2024 Financial Year Results' in January 2025, their Cosmetic Ingredients division reported high single-digit organic sales growth, attributed to robust demand in active botanicals and micro-protection segments.

In parallel, the push for sustainable and material-efficient packaging has evolved from a compliance requirement into a key competitive advantage. Companies are redesigning container architectures and dispensing systems to significantly lower plastic consumption and adopt circular design principles, appealing to environmentally conscious institutional clients. This movement aims to reduce the carbon footprint of hygiene delivery systems while preserving the effectiveness of the antimicrobial formulations. Industry dedication to this goal is illustrated by recent innovations; according to GOJO Industries' '2023-2024 Sustainable Value Report' from April 2025, the new Purell ES10 dispenser reduces plastic use by 30% compared to previous models, directly addressing market needs for waste reduction.

Key Market Players

  • Reckitt Benckiser Group PLC
  • Unilever Plc
  • GOJO Industries, Inc.
  • Henkel Corporation
  • Johnson & Johnson
  • The Himalaya Drug Company
  • Bielenda
  • Colgate-Palmolive Company
  • Sebapharma GmbH & Co. KG
  • Farouk Systems, Inc.

Report Scope

In this report, the Global Antibacterial Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Antibacterial Products Market, By Product

  • Hand Soap
  • Body Wash
  • HCream & Lotion
  • Others

Antibacterial Products Market, By Sales Channel

  • Supermarkets/Hypermarkets
  • Specialty Stores
  • Pharmacy & Drugstores
  • Online
  • Others

Antibacterial Products Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Antibacterial Products Market.

Available Customizations:

Global Antibacterial Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Antibacterial Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Hand Soap, Body Wash, HCream & Lotion, Others)
    • 5.2.2. By Sales Channel (Supermarkets/Hypermarkets, Specialty Stores, Pharmacy & Drugstores, Online, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Antibacterial Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Sales Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Antibacterial Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Sales Channel
    • 6.3.2. Canada Antibacterial Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Sales Channel
    • 6.3.3. Mexico Antibacterial Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Sales Channel

7. Europe Antibacterial Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Sales Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Antibacterial Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Sales Channel
    • 7.3.2. France Antibacterial Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Sales Channel
    • 7.3.3. United Kingdom Antibacterial Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Sales Channel
    • 7.3.4. Italy Antibacterial Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Sales Channel
    • 7.3.5. Spain Antibacterial Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Sales Channel

8. Asia Pacific Antibacterial Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Sales Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Antibacterial Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Sales Channel
    • 8.3.2. India Antibacterial Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Sales Channel
    • 8.3.3. Japan Antibacterial Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Sales Channel
    • 8.3.4. South Korea Antibacterial Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Sales Channel
    • 8.3.5. Australia Antibacterial Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Sales Channel

9. Middle East & Africa Antibacterial Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Sales Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Antibacterial Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Sales Channel
    • 9.3.2. UAE Antibacterial Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Sales Channel
    • 9.3.3. South Africa Antibacterial Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Sales Channel

10. South America Antibacterial Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Sales Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Antibacterial Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Sales Channel
    • 10.3.2. Colombia Antibacterial Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Sales Channel
    • 10.3.3. Argentina Antibacterial Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Antibacterial Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Reckitt Benckiser Group PLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Unilever Plc
  • 15.3. GOJO Industries, Inc.
  • 15.4. Henkel Corporation
  • 15.5. Johnson & Johnson
  • 15.6. The Himalaya Drug Company
  • 15.7. Bielenda
  • 15.8. Colgate-Palmolive Company
  • 15.9. Sebapharma GmbH & Co. KG
  • 15.10. Farouk Systems, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer